8124

532331

AJANTPHARM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AJANTA PHARMA LIMITED Share Price Today

AJANTA PHARMA LIMITED is currently trading at ₹3063.8, down by ₹9.8 from the previous close. The stock touched an intraday high of ₹3095.10 and a low of ₹3050.00 during the latest trading session. Over the past one year, AJANTA PHARMA LIMITED has delivered a return of 19.06%, while the stock has declined 4.37% in the last one month.

AJANTA PHARMA LIMITED performance

Today’s low Today’s high
₹ 3050.00 ₹ 3095.10
₹ 3073.60
52 week low 52 week high
₹ 2329.90 ₹ 3314.90
₹ 3073.60
Open Price ₹ 3091.20
Prev. Close ₹ 3073.60
Volume (Shares) 86653.00
Total traded value ₹ 2663.36
Upper Circuit ₹ 3688.30
Lower Circuit ₹ 2458.90
info

Investment Returns

Over 1 Month -4.37% Over 3 Months 0.55% Over 6 Months 18.20% Over 1 Year 19.06%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

AJANTA PHARMA LIMITED fundamentals


  • Market cap (Cr) 38,400.20
  • P/E Ratio (TTM) 40.58
  • Beta 0.51
  • Book Value / share 338.04
  • Return on equity 26.05%
  • EPS (TTM) 75.78
  • Dividend yield 0.91%
  • Net profit/quarter (Cr) 197.28
info icon alternate text
  • Market cap (Cr) 38,273.40
  • P/E Ratio (TTM) 40.58
  • Beta 0.48
  • Book Value / share 338.04
  • Return on equity 26.05%
  • EPS (TTM) 75.78
  • Dividend yield 0.91%
  • Net profit/quarter (Cr) 197.28
info icon alternate text

AJANTA PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 1210.53
Operating Expense 1015.90
Net Profit 197.28
Net Profit Margin (%) 16.29
Earnings Per Share (EPS) 15.79
EBITDA 301.03
Effective Tax Rate (%) 23.41
Particulars DEC 2025 (Values in Cr)
Revenue 1206.59
Operating Expense 909.89
Net Profit 245.04
Net Profit Margin (%) 20.30
Earnings Per Share (EPS) 19.61
EBITDA 366.71
Effective Tax Rate (%) 24.00
Particulars SEP 2025 (Values in Cr)
Revenue 1220.24
Operating Expense 973.30
Net Profit 249.53
Net Profit Margin (%) 20.44
Earnings Per Share (EPS) 19.98
EBITDA 364.62
Effective Tax Rate (%) 22.49
Particulars JUN 2025 (Values in Cr)
Revenue 1208.56
Operating Expense 920.20
Net Profit 254.97
Net Profit Margin (%) 21.09
Earnings Per Share (EPS) 20.41
EBITDA 370.03
Effective Tax Rate (%) 22.49
Particulars MAR 2025 (Values in Cr)
Revenue 1013.94
Operating Expense 803.71
Net Profit 193.43
Net Profit Margin (%) 19.07
Earnings Per Share (EPS) 15.46
EBITDA 267.58
Effective Tax Rate (%) 15.21
Particulars MAR 2026 (Values in Cr)
Revenue 4845.92
Operating Expense 3819.29
Net Profit 946.82
Net Profit Margin (%) 19.53
Earnings Per Share (EPS) 75.79
EBITDA 1402.38
Effective Tax Rate (%) 23.08
Particulars MAR 2025 (Values in Cr)
Revenue 4322.04
Operating Expense 3261.85
Net Profit 916.89
Net Profit Margin (%) 21.21
Earnings Per Share (EPS) 73.28
EBITDA 1324.59
Effective Tax Rate (%) 22.30
Particulars MAR 2024 (Values in Cr)
Revenue 3971.12
Operating Expense 2990.65
Net Profit 807.24
Net Profit Margin (%) 20.32
Earnings Per Share (EPS) 64.11
EBITDA 1235.91
Effective Tax Rate (%) 26.41
Particulars MAR 2023 (Values in Cr)
Revenue 3411.27
Operating Expense 2844.17
Net Profit 558.72
Net Profit Margin (%) 16.37
Earnings Per Share (EPS) 43.61
EBITDA 832.03
Effective Tax Rate (%) 20.16
Particulars MAR 2022 (Values in Cr)
Revenue 3140.64
Operating Expense 2379.83
Net Profit 719.86
Net Profit Margin (%) 22.92
Earnings Per Share (EPS) 55.52
EBITDA 1030.62
Effective Tax Rate (%) 20.06
Particulars MAR 2025 (Values in Cr)
Book Value / Share 302.38
ROE % 25.02
ROCE % 31.98
Total Debt to Total Equity 0.01
EBITDA Margin 29.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 282.34
ROE % 23.47
ROCE % 31.59
Total Debt to Total Equity 0.01
EBITDA Margin 29.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 268.14
ROE % 17.68
ROCE % 22.21
Total Debt to Total Equity 0.01
EBITDA Margin 23.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 380.24
ROE % 22.77
ROCE % 28.91
Total Debt to Total Equity 0.01
EBITDA Margin 31.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 344.52
ROE % 23.38
ROCE % 31.64
Total Debt to Total Equity 0.02
EBITDA Margin 35.46
Particulars MAR 2025 (Values in Cr)
Book Value / Share 289.21
ROE % 26.05
ROCE % 32.78
Total Debt to Total Equity 0.01
EBITDA Margin 30.65
Particulars MAR 2024 (Values in Cr)
Book Value / Share 270.17
ROE % 24.24
ROCE % 32.49
Total Debt to Total Equity 0.01
EBITDA Margin 31.12
Particulars MAR 2023 (Values in Cr)
Book Value / Share 256.94
ROE % 17.42
ROCE % 21.63
Total Debt to Total Equity 0.01
EBITDA Margin 24.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 369.15
ROE % 23.78
ROCE % 29.60
Total Debt to Total Equity 0.01
EBITDA Margin 32.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 331.80
ROE % 25.28
ROCE % 33.43
Total Debt to Total Equity 0.01
EBITDA Margin 37.54
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 176.24
Total Assets 5014.95
Total Liabilities 5014.95
Total Equity 3790.29
Share Outstanding 12
Price to Book Ratio 9.05
Return on Assets (%) 18.35
Return on Capital (%) 24.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 130.77
Total Assets 4638.39
Total Liabilities 4638.39
Total Equity 3567.36
Share Outstanding 12
Price to Book Ratio 8.28
Return on Assets (%) 17.59
Return on Capital (%) 22.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 330.90
Total Assets 4679.02
Total Liabilities 4679.02
Total Equity 3387.99
Share Outstanding 12
Price to Book Ratio 4.71
Return on Assets (%) 12.56
Return on Capital (%) 17.35
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 211.79
Total Assets 4055.58
Total Liabilities 4055.58
Total Equity 3264.34
Share Outstanding 8
Price to Book Ratio 4.90
Return on Assets (%) 17.57
Return on Capital (%) 21.82
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 209.61
Total Assets 3778.72
Total Liabilities 3778.72
Total Equity 2995.63
Share Outstanding 8
Price to Book Ratio 5.40
Return on Assets (%) 17.30
Return on Capital (%) 21.82
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 49.72
Total Assets 4554.25
Total Liabilities 4554.25
Total Equity 3625.31
Share Outstanding 12
Price to Book Ratio 9.05
Return on Assets (%) 20.13
Return on Capital (%) 25.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 63.06
Total Assets 4217.44
Total Liabilities 4217.44
Total Equity 3413.57
Share Outstanding 12
Price to Book Ratio 8.28
Return on Assets (%) 19.14
Return on Capital (%) 23.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 269.92
Total Assets 4304.79
Total Liabilities 4304.79
Total Equity 3246.45
Share Outstanding 12
Price to Book Ratio 4.71
Return on Assets (%) 12.97
Return on Capital (%) 17.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 145.25
Total Assets 3780.49
Total Liabilities 3780.49
Total Equity 3169.18
Share Outstanding 8
Price to Book Ratio 4.90
Return on Assets (%) 19.04
Return on Capital (%) 22.71
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 151.98
Total Assets 3532.06
Total Liabilities 3532.06
Total Equity 2884.98
Share Outstanding 8
Price to Book Ratio 5.40
Return on Assets (%) 19.12
Return on Capital (%) 23.42
Particulars MAR 2025 (Values in Cr)
Net Income 1189.16
Cash from Operations 1480.20
Cash from Investing -376.52
Cash from Financing -733.41
Net change in Cash 47.30
Free Cash Flow 1798.12
Particulars MAR 2024 (Values in Cr)
Net Income 1113.93
Cash from Operations 1097.20
Cash from Investing 65.39
Cash from Financing -1051.06
Net change in Cash -200.60
Free Cash Flow 1249.61
Particulars MAR 2023 (Values in Cr)
Net Income 745.25
Cash from Operations 943.40
Cash from Investing -559.60
Cash from Financing -108.20
Net change in Cash 124.31
Free Cash Flow 1117.88
Particulars MAR 2022 (Values in Cr)
Net Income 909.48
Cash from Operations 800.84
Cash from Investing -74.10
Cash from Financing -459.71
Net change in Cash 27.90
Free Cash Flow 949.68
Particulars MAR 2021 (Values in Cr)
Net Income 900.18
Cash from Operations 806.70
Cash from Investing -282.38
Cash from Financing -318.29
Net change in Cash -24.36
Free Cash Flow 978.31
Particulars MAR 2025 (Values in Cr)
Net Income 1180.06
Cash from Operations 1335.63
Cash from Investing -349.60
Cash from Financing -715.71
Net change in Cash -11.51
Free Cash Flow 1652.83
Particulars MAR 2024 (Values in Cr)
Net Income 1096.95
Cash from Operations 987.63
Cash from Investing 105.02
Cash from Financing -1047.70
Net change in Cash -207.33
Free Cash Flow 1140.20
Particulars MAR 2023 (Values in Cr)
Net Income 699.85
Cash from Operations 861.85
Cash from Investing -501.31
Cash from Financing -105.12
Net change in Cash 129.86
Free Cash Flow 1037.51
Particulars MAR 2022 (Values in Cr)
Net Income 900.54
Cash from Operations 735.81
Cash from Investing -66.04
Cash from Financing -457.30
Net change in Cash 19.00
Free Cash Flow 882.33
Particulars MAR 2021 (Values in Cr)
Net Income 902.09
Cash from Operations 664.90
Cash from Investing -162.68
Cash from Financing -268.90
Net change in Cash 35.41
Free Cash Flow 831.87
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.03 13.24 1.55 245.46 23.12 38.85
BLISS GVS PHARMA LTD. 481.70 39.10 4.28 5108.73 118.35 486.15
CIPLA LTD 1355.80 28.77 3.18 109527.67 1165.55 1672.20
FERMENTA BIOTECH LTD. 318.45 14.05 2.30 937.23 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.03 22.40 4.12 245.46 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 544.75 24.42 4.25 1574.91 490.00 789.95
ASTRAZENECA PHARMA IND LT 8514.50 111.20 24.38 21286.25 7630.00 10033.55
BLISS GVS PHARMA LTD. 481.70 51.96 4.42 5108.73 118.35 486.15

AJANTA PHARMA LIMITED shareholding pattern

Holding
7.12%
66.24%
8.26%
18.36%
17.94%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

AJANTA PHARMA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
3073.60 0.00 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 3075.30
  • 26 Days 3037.80
  • 10 Days 3062.80
  • 50 Days 2998.40
  • 12 Days 3059.00
  • 100 Days 2924.40
  • 20 Days 3047.20
  • 200 Days 2835.60
3075.43 PIVOT
First Support 3050.97 First Resistance 3098.07 Second Support 3028.33 Second Resistance 3122.53 Third Support 3003.87 Third Resistance 3145.17
RSI 53.99 ADX 10.64 MACD 21.25 Williams % R -32.16 Commodity Channel Index (CCI) 35.00
Date 2026-06-18 Week 63283.00 Same Day 50285.00 Month 66782.00
1 Year 0.52 3 Year 0.45
Over 1 Month
-4.37% down
Over 1 Year
19.06% down
Over 3 Months
0.55% down
Over 3 Years
27.75% down
Over 6 Months
18.20% down
Over 5 Years
18.80% down

AJANTA PHARMA LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
10 Nov 2025 28.0 Interim 1 10 Nov 2025 Equity shares
06 Nov 2024 28.0 Interim 1 06 Nov 2024 Equity shares
08 Feb 2024 26.0 Interim 2 08 Feb 2024 Equity shares
04 Aug 2023 10.0 Interim 1 04 Aug 2023 Equity shares
04 Aug 2023 15.0 Special 04 Aug 2023 Equity shares
11 Nov 2022 7.0 Interim 14 Nov 2022 Equity shares
09 Nov 2021 9.5 Interim 10 Nov 2021 Equity shares
12 Nov 2020 9.5 Interim 13 Nov 2020 Equity shares
15 Nov 2019 13.0 Interim 18 Nov 2019 Equity shares
09 Nov 2018 9.0 Interim 12 Nov 2018 Equity shares
23 Mar 2017 7.0 Interim 2 25 Mar 2017 Equity shares
07 Nov 2016 6.0 Interim 08 Nov 2016 Equity shares
17 Mar 2016 8.0 Interim 19 Mar 2016 Equity shares
25 Jun 2015 6.0 Final 27 Jun 2015 Equity shares
24 Jul 2014 10.0 Final 28 Jul 2014 Equity shares
18 Jul 2013 6.25 Final 22 Jul 2013 Equity shares
28 Jun 2012 7.5 Final 02 Jul 2012 Equity shares
23 Jun 2011 5.0 Final 25 Jun 2011 Equity shares
29 Jun 2010 3.5 Final 01 Jul 2010 Equity shares
30 Jun 2009 2.5 Final 03 Jul 2009 Equity shares
27 Jun 2008 2.5 Final 01 Jul 2008 Equity shares
19 Sep 2007 2.0 Final 21 Sep 2007 Equity shares
Ex-Date Ex-Bonus Ratio
23 Jun 2022 22 Jun 2022 1:2
18 Sep 2013 17 Sep 2013 1:2
Ex-Date Old FV NEW FV Record Date
20 Mar 2015 5.0 2.0 23 Mar 2015
09 Aug 2012 10.0 5.0 10 Aug 2012
Dividend date Dividend amount Dividend type Record date Instrument type
10 Nov 2025 28.0 Interim 1 10 Nov 2025 Equity shares
06 Nov 2024 28.0 Interim 1 06 Nov 2024 Equity shares
08 Feb 2024 26.0 Interim 2 08 Feb 2024 Equity shares
04 Aug 2023 10.0 Interim 1 04 Aug 2023 Equity shares
04 Aug 2023 15.0 Special 04 Aug 2023 Equity shares
11 Nov 2022 7.0 Interim 14 Nov 2022 Equity shares
09 Nov 2021 9.5 Interim 10 Nov 2021 Equity shares
12 Nov 2020 9.5 Interim 13 Nov 2020 Equity shares
15 Nov 2019 13.0 Interim 18 Nov 2019 Equity shares
09 Nov 2018 9.0 Interim 12 Nov 2018 Equity shares
23 Mar 2017 7.0 Interim 2 25 Mar 2017 Equity shares
07 Nov 2016 6.0 Interim 08 Nov 2016 Equity shares
17 Mar 2016 8.0 Interim 19 Mar 2016 Equity shares
25 Jun 2015 6.0 Final 27 Jun 2015 Equity shares
24 Jul 2014 10.0 Final 28 Jul 2014 Equity shares
18 Jul 2013 6.25 Final 22 Jul 2013 Equity shares
28 Jun 2012 7.5 Final 02 Jul 2012 Equity shares
23 Jun 2011 5.0 Final 25 Jun 2011 Equity shares
29 Jun 2010 3.5 Final 01 Jul 2010 Equity shares
30 Jun 2009 2.5 Final 03 Jul 2009 Equity shares
27 Jun 2008 2.5 Final 01 Jul 2008 Equity shares
19 Sep 2007 2.0 Final 21 Sep 2007 Equity shares
Ex-Date Ex-Bonus Ratio
23 Jun 2022 22 Jun 2022 1:2
18 Sep 2013 17 Sep 2013 1:2
Ex-Date Old FV NEW FV Record Date
20 Mar 2015 5.0 2.0 23 Mar 2015
09 Aug 2012 10.0 5.0 10 Aug 2012

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Ajanta Pharma Ltd?

Answer Field

Ajanta Pharma Ltd share price is for NSE ₹ 3,063.80 & for BSE ₹ 3,067.35 as on Jun 19 2026 12:55 PM.

What is the Market Cap of Ajanta Pharma Ltd Share?

Answer Field

The market cap of Ajanta Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 19 2026 12:55 PM.

What is the 52 Week High and Low of Ajanta Pharma Ltd?

Answer Field

The 52 Week High and Low of Ajanta Pharma Ltd for NSE is ₹ 3,314.90 and ₹ 2,329.90 and for BSE is ₹ 3,314.80 and ₹ 0.00.

What is 1 year return for Ajanta Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 19.06%.

What is the P/E Ratio of Ajanta Pharma Ltd Share?

Answer Field

As on Jun 19 2026 12:55 PM the price-to-earnings (PE) ratio for Ajanta Pharma Ltd share is 40.58.

What is the PB ratio of Ajanta Pharma Ltd Share?

Answer Field

As on Jun 19 2026 12:55 PM, the price-to-book (PB) ratio for Ajanta Pharma Ltd share is 338.04.

How to Buy Ajanta Pharma Ltd Share?

Answer Field

You can trade in Ajanta Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ajanta Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Ajanta Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ajanta Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|